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Abstract 
A series of N α-acyl (alkyl)- and N α-alkoxycarbonyl-derivatives of l- and d-ornithine were prepared, characterized, 
and analyzed for their potency toward the bacterial enzyme N α-acetyl-l-ornithine deacetylase (ArgE). ArgE 
catalyzes the conversion of N α-acetyl-l-ornithine to l-ornithine in the fifth step of the biosynthetic pathway for 
arginine, a necessary step for bacterial growth. Most of the compounds tested provided IC50 values in the μM 
range toward ArgE, indicating that they are moderately strong inhibitors. N α-chloroacetyl-l-ornithine (1g) was 
the best inhibitor tested toward ArgE providing an IC50 value of 85 μM while N α-trifluoroacetyl-l-ornithine (1f), N 
α-ethoxycarbonyl-l-ornithine (2b), and N α-acetyl-d-ornithine (1a) weakly inhibited ArgE activity providing IC50 
values between 200 and 410 μM. Weak inhibitory potency toward Bacillus subtilis-168 for N α-acetyl-d-ornithine 
(1a) and N α-fluoro- (1f), N α-chloro- (1g), N α-dichloro- (1h), and N α-trichloroacetyl-ornithine (1i) was also 
observed. These data correlate well with the IC50 values determined for ArgE, suggesting that these compounds 
might be capable of getting across the cell membrane and that ArgE is likely the bacterial enzymatic target. 
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Abbreviations 
AA  Amino acid analysis 
CAN  Acetonitrile 
ArgE  Nα-acetyl-l-ornithine deacetylase 
Boc  tert-Butoxycarbonyl 
(Boc)2O  Di-(tert-butylcarbonate) anhydride 
DIC  NN-Diisopropylcarbodiimide 
DCM  Dichloromethane 
DIEA  NN-Diisopropylethylamine 
DMAP  4-(Dimethylamino)pyridine 
DMF  NN-Dimethylformamide 
ESI MS  Electro spray ionization mass spectrometry 
Et  Ethyl 
Fmoc  [(Fluoren-1-yl-methoxy]carbonyl; 9-fluorenylmethoxycarbonyl 
HEPES  4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
HOBt  1-Hydroxybenzotriazole 
IPTG  Isopropyl-β-d-thiogalactopyranoside 
Me  Methyl 
NAO  N-Acetyl-l-ornithine 
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
TFA  Trifluoroacetic acid 
TIS  Tri-isopropylsilane 
Tricine  N-tris[hydroxymethyl]methylglycine 
Z  Benzyloxycarbonyl 
 
The nomenclature and symbols of amino acids follow the Recommendations of IUPAC/IUB Joint Commission on 
Biochemical Nomenclature. Eur J Biochem (1984) 138: 9–37. 
Introduction 
The increasing resistance of microorganisms to antimicrobial agents represents a serious public health problem 
(Hancock 1997). Today 1,500 people die each hour from an infectious disease; half of these are children under 
5 years of age (Levy 1998). The Institute of Medicine, a part of the National Academy of Sciences, has estimated 
that the annual cost of treating antibiotic resistant infections in the US alone may be as high as $30 billion (CDC 
1995). These findings have stimulated a sustained search for new potent antimicrobial agents against drug 
resistant bacterial strains as well as new enzymatic targets (Teuber 1999). Microbial enzymes, especially those 
catalyzing metabolic processes exclusive to bacteria, are potential targets for potent and selective antibiotics. 
Since many of the broad-spectrum antibiotics contain β-lactam functional units that target enzymes involved in 
bacterial cell wall synthesis or pathways involved in cell replication (Levy 1998; Nemecek 1997), new enzymatic 
targets must be located so novel inhibitors can be synthesized, providing new classes of antibiotics. For this 
reason, several bacterial metallohydrolases containing dinuclear active sites have become the subject of intense 
efforts in inhibitor design (Holz et al. 2003; Bradshaw and Yi 2002; Daiyasua et al. 2001; Lipscomb and Sträter 
1996; Wilcox 1996; Dismukes 1996). 
 
The argE-encoded N α-acetyl-l-ornithine deacetylase (EC 3.5.1.16; ArgE) is a bacterial metallohydrolase that 
contains a dinuclear active site and is a member of the arginine biosynthetic pathway in bacteria (McGregor et 
al. 2005). Prokaryotes synthesize arginine through a series of eight enzymatically catalyzed reactions that differ 
from those of eukaryotes by two key steps: (i) acetylation of glutamate and (ii) the subsequent deacetylation of 
the arginine precursor N α-acetyl-l-ornithine (NAO) by ArgE (Cunin et al. 1986; Davis 1986; Ledwidge and 
Blanchard 1999). The arginine biosynthetic pathway is found in all Gram-negative and most Gram-positive 
bacteria including Enterobacteriaceae (Vogel and MacLellan 1970), Myxococcus (Harris and Singer 1998), 
Vibrionaceae (Xu et al. 2000), and the thermophilic archaeon Sulfelobus (Van de Casteele et al. 1990). Because 
ornithine is required, not only for the synthesis of arginine in bacteria, but also for polyamines involved in DNA 
replication and cell division, NAO deacetylation is critical for bacterial proliferation (Girodeau et al. 1986). 
Indeed, when an arginine auxotrophic bacterial strain void of NAO deacetylase activity was transformed with a 
plasmid containing argE, an Arg+ phenotype resulted (Meinnel et al. 1992). However, when the start codon 
(ATG) of argE in the same plasmid was changed to the Amber codon (TAG), the resultant plasmid was unable to 
relieve arginine auxotrophy in the same cell strain, therefore, ArgE is required for cell viability. 
 
ArgE catalyzes the conversion of N α-acetyl-l-ornithine to l-ornithine (Velasco et al. 2002) (Fig. 1). The substrate 
specificity of ArgE is broad in that several N α-acylamino acids can be hydrolyzed including N α-acetyl- or N α-
formylmethionine and N α-acetylornithine (Javid-Majd and Blanchard 2000). Few inhibitors have been reported 
for ArgE (McGregor et al. 2007) to date, and fluoride ions were shown to be uncompetitive inhibitors exhibiting 
a modest K i of 3.4 mM. Due to the crucial role ArgE plays in prokaryotic cell growth and proliferation, the 
development of specific and potent inhibitors of ArgE is of key importance. For that reason, we have designed a 
series of ornithine derivatives (Fig. 2) that were hypothesized to function as inhibitors of ArgE. 
 
  
Fig. 1. Conversion of N α-acetyl-l-ornithine to l-ornithine, catalyzed by ArgE 
 
  
Fig. 2. General formula and structures of the ornithine 1a–1l and 2a–2f derivatives 
 
Compounds 1a–1j (Fig. 3), 1k, 1l (Fig. 4), and 2a–2f (Fig. 5) were synthesized and characterized, where the 
natural N α-acetyl substituent was replaced. This general modification renders the corresponding amide bond 
resistant to hydrolytic cleavage by ArgE. Therefore, replacement of the N α-acetyl substituent was hypothesized 
to provide small molecule inhibitors of ArgE, which in turn may cause an interruption in the arginine 
biosynthetic pathway of bacteria, inhibiting their growth. In an effort to gain insight into structure–activity 
relationships of this series of ornithine (Orn) derivatives, we determined their inhibitory potency toward the 
ArgE from Escherichia coli (Table 1). Most of the compounds tested provided IC50 values in the μM range, 
indicating that they are moderately strong inhibitors. Weak inhibitory potency for a few of these Orn derivative 
toward Bacillus subtilis-168 was observed indicating that these derivatives are capable of getting across the cell 
membrane and that ArgE is the likely bacterial enzymatic target. 
  
Fig. 3. Synthetic scheme for the preparation of the N α-acyl-ornithine derivatives 1a–1j  
 
  
Fig. 4. Synthetic scheme for the preparation of the N α-alkyl-ornithine derivatives 1k–1l  
 
  
Fig. 5. Synthetic scheme for the preparation of the N α-alkyloxycarbonyl-ornithine derivatives 2a–2f  
 
Table 1. Analytical data and inhibitory activities of Orn 1a–1l and 2a–2f derivatives 
Compound Formulaa Calc./found 
(m/z) 
HPLC RT 
(min)b−d  
ArgE IC50 value in 
mM 
B. subtilis μge MIC 
(μM)f 
1ag,R=CH3 C7H14N2O3  
174.2/175.1 
2.85 0.41 ± 0.1 26.0 
250 
1b, R=CH3)3C C10H20N2O3  
216.3/217.1 
11.02 ~5.4 19.5  
h 
1c, R=(CH3)2CH C9H18N2O3  11.22 1.21 ± 0.2 26.2  
202.3/203.1 h 
1d, R=CH3(CH2)2 C9H18N2O3  
202.3/203.1 
11.12 0.42 ± 0.08 26.1 
i 
1e, R=CH3CH2 C8H16N2O3  
188.2/189.1 
7.05 0.76 ± 0.04 26.0  
h 
1f, R=CF3 C7H11N2O3F3  
228.2/229.1 
4.34 0.20 ± 0.04 23.9 
250 
1g, R=CH2Cl C7H13N2O3Cl 
208.6/209.2 
7.32 0.085 ± 0.007 21.7 
250 
1h, R=CHCl2 C7H12N2O3Cl2  
243.1/243.1 
7.41 0.34 ± 0.03 41.2 
500 
1i, R=CCl3 C7H11N2O3Cl3  
277.5/276,9 
7.68 0.45 ± 0.03 28.2 
500 
1jg, R=CCl3 C7H11N2O3Cl3  
277.5/276,9 
7.72 0.32 ± 0.02 28.2 
i 
1 k, C2H5–
Orn(lactam) 
C7H14N2O 
142.2/143.2 
5.02 2.5 ± 0.2 22.1  
h 
1l, C2H5–Orn–OH C7H16N2O2  
160.21/161.1 
4.21 2.7 ± 0.2 22.3  
h 
2a, R=CH3O C7H14N2O4  
190.1/191.0 
4.12 1.01 ± 0.11 26.1 
i 
2b, R=C2H5O C8H16N2O4  
204.2/205.1 
5.22 0.25 ± 0.07 28.1 
i 
2c, R=(CH3)2CHCH2O C10H20N2O4  
232.3/233.3 
9.51 1.16 ± 0.14 32.0  
h 
2d, R=(CH3)2CHO C9H18N2O4  
218.2/219.2 
7.56 1.40 ± 0.09 26.0  
h 
2e, R=CH3(CH2)2O C9H18N2O4  
218.2/218.2 
7.58 0.71 ± 0.05 26.2 
i 
2f, R=(CH3)3CO C10H20N2O4  
232.3/233.3 
9.17 0.54 ± 0.05 29.0 
i 
Tetracycline C22H24N2O8  
444.4/445.3 
    45.2 
12.5 
aDetermined with ESI MS technique 
bFor HPLC a TSP instrument with an SP 8800 pump, an SP 4290 integrator, TSP Spectra 100 UV detector and 
5 μm Supelco 15 × 0.4 cm column, 20 min gradient 0–50% ACN in 0.05% TFA and for compounds 1a, 1k, 1l, 2a–
2d an isocratic analysis with 0.05% TFA were used 
cElectrophoretic mobilities of derivatives 1a–1e were in the range 0.92–1.14 (Gly) and 0.49–0.63 (His), those of 
the 2a–2f were in the range 0.85–1.05 (Gly) and 0.41–0.52 (His), in 6% AcOH of the pH 2.4 
dAll compounds of series 1 and 2 gave correct elemental analyses of C, H, and N atoms in the range of 0.3% 
eMaximal quantity of compound applied in agar plate 
fMIC tested in concentrations 0.5–500 μM, tetracycline standard in the concentration range 0.5–500 μM 
gCompound with d-Orn 
hNo inhibition 
iVery weak inhibitor 
Materials and methods 
General methodologies 
H–N δ–Z–Orn–OH was purchased from NovaBiochem, Switzerland and N α–Fmoc–N δ–Boc–Orn–OH, Wang resin 
(substitution 1.1 mmol/g) and triphosgene from Iris Comp, Germany. DIC, HOBt, DIEA, and reagents for N α-
acylation were purchased from Sigma-Aldrich, Czech Republic. Products were dried in a vacuum dry box (Salvis 
AG, Emmenbrűcke-Luzern, Switzerland) at room temperature for 16 h. Tetracycline, LB broth, and LB agar were 
purchased from Sigma-Aldrich. The test organisms used were: B. subtilis 168, kindly provided by Prof. Yoshikava 
(Princeton University, NJ) and E. coli B from the Czech Collection of Microorganisms (Brno, Czech Republic). 
Electrophoresis was carried out in a modified moist chamber apparatus (Durrum 1950) on Whatman No. 3 MM 
paper at 20 V/cm using 6% aqueous acetic acid (pH 2.5) and pyridine–acetate buffer (pH 5.7) as the electrolytes 
for 45 min. Electrophoretic mobilities E 2.4 Gly , E 2.4 His , and E 5.7 His , respectively, were expressed as the distance 
ratios of the compound and the reference amino acids Gly and His from the start line. Dried papers were stained 
with a 1% solution of ninhydrine in ethanol. Molecular weights of the compounds prepared were determined by 
mass spectroscopy using an ESI technique (Agilent 5975B MSD) from Agilent Technologies, USA. For HPLC, an SP 
8800 pump and a TSP Chrom Jet SP4290 integrator and Spectra 100 UV detector were used. The ornithine 
derivatives were purified by semi-preparative HPLC on a Vydac RP-18, 25 × 1 cm, 10 μm column (Separation 
Groups, Hesperia, USA), flow rate 3 ml/min, detection at 220 nm, using an isocratic 0.05% aqueous TFA mobile 
phase. Analytical HPLC was carried out on a Supelco RP-18 Discovery 15 × 0.4 cm column, 5 μm (Supelco-Sigma-
Aldrich, Czech Republic), with a flow rate of 1 ml/min at 220 nm, using a 0–100% gradient of ACN in 0.05% 
aqueous TFA over 40 min. Elemental analyses were performed at the Analytical Laboratory of the Institute of 
Organic Chemistry and Biochemistry, CAS. 1H NMR and 13C NMR spectra were recorded on a spectrometer 
AVANCE-600 (1H at 600.13 MHz; 13C at 150/90 MHz) from Brucker BioSpin Corporation (Billerica, MA, USA). 
 
Synthesis of Orn derivatives 
Nδ–Boc–Orn–O–Wang resin (Fig. 3) 
To the Wang resin (5 g, 5.5 mmols of OH groups), swollen in DMF (3 × 20 ml), a solution of N α–Fmoc–N δ–Boc–
Orn–OH (6 eq.; 15.0 g; 33.0 mmol), HOBt (6.6 eq.; 4.86 g; 36.3 mmol), DIC (6.6 eq.; 7.78 ml; 36.3 mmol), and 
DMAP (0.6 eq.; 0.4 g; 3.3 mmol) in DMF (30 ml) was added. This reaction mixture was stirred for 3 days at room 
temperature and then the resin was filtered and washed with 3 × 30 ml of DMF, 2-propanol, and DMF. After N α-
Fmoc group removal by 20% piperidine in DMF (20 ml) for 10 and 30 min, the H–N δ–Boc–Orn–O–Wang resin 
was filtered, successively washed with 3 × 30 ml of DMF, 2-propanol, and MeOH and was dried in a desiccator 
over calcium chloride. The amount of Orn loaded onto the resin was found to be 0.45 mmol/g based on amino 
acid analysis (AA). 
 
Nα-Acylderivatives of ornithine 1a–1j (Fig. 3; Table 1) 
A solution of carboxylic acid (10 eq.; 3.9 mmol), HOBt (11 eq.; 0.58 g; 4.3 mmol), and DIC (11 eq.; 0.92 ml; 
4.3 mmol) or an acetanhydride/DIEA mixture 2:3 (5 ml) in DMF (10 ml) was added to H–N δ–Boc–L–Orn–O–Wang 
resin or H–N δ–Boc–D–Orn–O–Wang resin (0.9 g; 0.39 mmol of Orn, loaded at 0.43 mmol/g). The reaction 
mixture was stirred for 1 day at room temperature, filtered, and washed with DMF, 2-propanol, and MeOH 
(3 × 10 ml). A ninhydrine test (Kaiser et al. 1970) was used to check the level of completion of the N-acylation 
reaction. When a slight blue color persisted, re-coupling was again carried out using 50% of the reagent amounts 
listed above reacted for 12 h. Detachment of the corresponding ornithine derivative from the resin and 
deprotection of the side-chain (removal of N δ–Boc) were performed simultaneously by treating with a 50% TFA–
5% anisole–5% TIS mixture in DCM (10 ml). Finally, the solution was evaporated in vacuo to dryness at 30°C and 
the residue was triturated with tert-butyl-methyl ether and anhydrous diethyl ether. The corresponding N α-acyl-
Orn-OH derivative was purified using preparative HPLC under conditions described in the “General 
Methodologies” section and characterized by analytical HPLC, ESI MS spectroscopy, elemental analysis, and 
electrophoresis (Table 1) and 1H NMR (Table 2) and 13C NMR (Table 3) spectroscopy. 
 
Table 2. Proton NMR data of ornithine derivatives in DMSO 
Compound HN Hα Hβ Hγ Hδ NH2  R 
1a  8.21 d 
(J = 7.8) 
4.18 m 1.75 m 
1.57 m 
1.57 m 2.78 m 7.83 b CH3CO: 1.85 s 
1b  7.11 d 
(J = 5.5) 
3.71 dt 1.67 m 1.53 m 
1.47 m 
2.74 m 
2.70 m 
7.76 b (CH3)3C: 1.10 s 
1c  8.05 d 
(J = 8.2) 
4.18 dt 1.77 m 
1.59 m 
1.56 m 2.77 m 7.74 b (CH3)2: 0.99 d, J = 6.8; 1.00 d, J = 6.8; 
CH: 2.44 h, J = 6.8 
1d  8.12 d 
(J = 8.0) 
4.19 dt 1.77 m 
1.59 m 
1.56 m 2.78 m 7.73 m CH3: 0.85 t, J = 7.4; CH2: 1.51 m; 
CH2CO: 2.09 t, J = 7.3 
1e  8.10 d 
(J = 8.0) 
4.19 dt 1.76 m 
1.58 m 
1.56 m 2.78 m 7.74 b CH3: 0.99 t, J = 7.6; CH2CO: 2.13 q, 
J = 7.6 
1f  9.77 b 4.27 
um 
1.90 m 
1.74 m 
1.58 m 2.79 m 7.76 b – 
1g  8.57 d 
(J = 7.8) 
4.23 
ddd 
1.81 m 
1.64 m 
1.56 m 2.78 
bt 
7.75 b CH2Cl: 4.12 s 
1h  8.95 d 
(J = 7.7) 
4.22 dt 1.84 m 
1.68 m 
1.56 m 2.79 
bt 
7.79 b CHCl2: 6.55 s 
1i  9.19 bd 4.18 m 1.91 m 
1.80 m 
1.58 m 2.78 m 7.82 b – 
1j  9.18 bd 4.20 m 1.93 m 
1.83 m 
1.59 m 2.79 m 7.81 b – 
1k  8.80 b 4.12 
ddd 
2.20 m 
1.65 m 
1.90 m 
1.77 m 
3.14 m 
3.17 m 
8.21 b CH3: 1.19 t, 
CH2NH: 2.98 m 
1l  ~3.50 b 3.94 m 1.99 m 
1.90 m 
1.76 m 
1.62 m 
2.77 m 8.25 b CH3: 1.23 t, J = 7.3, CH2: 2.95 m 
2a  6.40 d 3.66 q 1.64 m 1.50 m 2.71 m 7.81 b CH3O: 3.50 s 
2b  7.12 d 3.84 m 1.73 m 
1.59 m 
1.57 m 2.76 m 7.74 b CH3: 1.15 t; CH2O: 3.97 m 
2c*  7.31 d 
(J = 8.0) 
3.89 m 1.74 m 
1.58 m 
1.58 m 2.77 m 7.78 b CH3: 0.85 t + 0.845 t, J = 7.4; 1.13 
d + 1.135 d, J = 6.3; CH2: 1.49 m; CH–
O: 4.58 m 
2d  7.21 d 
(J = 7.8) 
3.87 m 1.73 m 
1.58 m 
1.58 m 2.76 m 7.74 b CH3: 1.165 d and 1.160 d, J = 6.3; 
CH–O: 4.73 h, J = 6.3 
2e  6.20 bd 
(J ~ 6.0) 
3.59 q 1.64 m 1.46 m 2.68 m 7.73 b CH3: 0.87 t, J = 7.4; CH2: 1.53 m; 
CH2–O: 3.85 m 
2f  5.955 d 
(J = 5.5) 
3.52 bq 1.64 m 1.54 m 
1.47 m 
2.70 m 7.77 b (CH3)3C: 1.365 s 
*Mixture of diastereoisomers 1:1 (some signals are doubled) 
 
Table 3. Carbon-13 NMR data for each ornithine derivative in DMSO 
Compound Cα Cβ Cγ Cδ COOH R 
1a  51.55 28.31 24.04 38.72 173.69 CH3: 22.60; CONH: 169.68 
1b  53.43 29.40 23.41 38.96 176.14 t-Bu: 27.63; >C<: 80.50; CONH: 174.01 
1c  51.32 28.29 24.13 38.78 173.77 (CH3)2: 19.64, 19.83; >CH–: 33.92; CONH: 176.65 
1d  51.43 28.26 24.11 38.75 173.74 CH3: 13.85; CH2: 18.94; CH2: 37.24; CONH: 172.76 
1e  51.42 28.32 24.07 38.75 173.74 CH3: 10.10; CH2: 28.44; CONH: 173.41 
1f  52.40 27.12 24.14 38.58 171.86 CF3: 116.07 q, J(C,F) = 288.1; CONH: 156.78 q, 
J(C,F) = 36.5 
1g  51.98 28.21 23.92 38.70 173.04 CH2Cl: 42.61; CONH: 166.32 
1h  52.50 28.19 23.88 38.86 172.52 CHCl2: 66.70; CONH: 163.84 
1i  5374 27.21 24.34 38.82 172.18 CCl3: 92.81; CONH: 161.66 
1j  53.84 27.11 24.24 38.84 172.13 CCl3: 92.78; CONH: 161.64 
1k  54.30 22.72 20.29 40.61 166.92 CH3: 11.16, CH2NH: 39.76 
1l  58.01 26.04 22.87 38.26 170.23 CH3: 11.24; CH2: 41.19 
2a  54.96 29.47 23.35 38.86 174.20 CH3O: 51.45; OCONH: 156.00 
2b  53.86 28.43 24.01 38.75 174.01 CH3: 14.37; CH2O: 60.03; OCONH: 156.31 
2c*  53.55 28.01 
27.97 
24.19 38.73 173.94 CH3: 9.83 and 19.82; CH2: 28.81 + 28.88; 
CH–O: 71.68 + 71.70; OCONH: 156.38 
2d  53.62 28.15 24.14 38.73 173.98 CH3: 22.28 and 22.30; CH–O: 67.23; 
OCONH: 156.08 
2e  54.89 29.77 23.98 39.19 173.69 CH3: 10.54; CH2: 22.27; CH2–O: 65.27; OCONH: 
155.54 
2f**  58.14 
(59.61) 
31.54 26.12 
(26.32) 
41.78 182.04 (CH3)3: 30.40 (30.29); >C<: 83.85; OCONH: 160.37 
*A mixture of diastereoisomers 1:1 was observed (some signals are doubled) 
**D2O was used as this molecues is insufficiently soluble in DMSO; some carbon signals are doubled (hindered 
rotation around C–N bond) 
 
HCl·H–N δ–Z–Orn–OMe 
Methylester was prepared according to the literature (Brenner and Huber 1953): anhydrous MeOH (30 ml) was 
added to SOCl2 (5 ml; 33 mmol) dropwise at −5°C with stirring. H–N δ–Z–Orn–OH (7.99 g; 30 mmol) was added 
and stirring was continued at room temperature until the solid dissolved. After 2 h the reaction mixture was 
evaporated to dryness, the resulting residue was dissolved in MeOH and the evaporation repeated. 
Electrophoresis E 2.4 Gly 1.15; E 2.4 His 0.73; E 5.7 His 0.86 indicated ~10% of the starting acid in the final product. 
Therefore, the esterification procedure was repeated using the same conditions. The second esterification 
afforded product (7.7 g; 24.4 mmol; 81%), which was free of the starting acid and was used directly for the 
synthesis of compounds 1k, 1l, and the corresponding isocyanate in the synthesis of compounds 2a–2e. 
 
Nα–Ethyl–Orn–OH 1l and corresponding lactam 1k (Fig. 4; Table 1) 
Chilled acetaldehyde (0.63 ml; 3.84 mmol; 3 eq.) was added to a stirred DMF (15 ml) solution of HCl·H–N δ–Z–
Orn–OMe (0.38 g; 1.28 mmol) in the presence of DIEA (0.25 ml; 1.5 mmol) at 0°C. NaBH3CN (0.45 g; 3.84 mmol; 
3 eq.) in DMF (12 ml) was added to the reaction mixture within 2 min at 0°C. After elevation to room 
temperature, the mixture was stirred for another 3 h. The solvent was evaporated and the above reaction 
repeated with acetaldehyde (0.21 ml; 1.28 mmol) and NaBH3CN (0.15 g; 1.28 mmol) in DMF (12 ml) and stirred 
for another 5 h. The DMF was again evaporated and the residue dissolved in ethyl acetate. This solution was 
washed with water and dried with anhydrous Na2SO4. ESI mass for C2H5–Orn(Z)–OCH3 (C16H24N2O4, 308.2) was 
found to be m/z: 309.1 (M + H+). This compound (0.28 g; 0.91 mmol) was hydrogenated with 10% Pd on charcoal 
(50 mg) in MeOH (10 ml) for 3 h at room temperature. After filtration of the catalyst and evaporation of the 
solvent, the semi-oily residue (0.16 g; 0.89 mmol) was found to be the lactam 1k with the formula C2H5–NH–
CH(CH2CH2CH2NHCO). ESI mass was determined for C7H14N2O (142.2), m/z: 143.1(M + H+); 1H NMR and 13C NMR 
results are provided in Tables 2 and 3. Treatment with boiling 6 M HCl (10 ml) for 2 h, opened the lactam. The 
solvent was evaporated resulting in compound 1l, which was characterized by ESI MS spectroscopy, elemental 
analysis, electrophoresis (Table 1), and 1H NMR and 13C NMR spectroscopy (Tables 2, 3). 
 
Ornithine derivatives 2a–2e (Fig. 5; Table 1) 
A solution of HCl·H–N δ–Z–Orn–OMe (6.3 g; 20 mmol) and triphosgene (1.97 g; 6.59 mmol) in DCM (78.3 ml) was 
stirred vigorously in the presence of saturated aqueous NaHCO3 (78.3 ml) on ice for 30 min. The reaction 
mixture was poured into a separatory funnel. The organic layer was collected and the aqueous layer was washed 
three times with DCM (13 ml). The combined organic layers were dried with MgSO4, filtered, and evaporated at 
reduced pressure to give a colorless oil that turned, upon refrigeration, into a white solid, that was triturated 
with a light petroleum to yield 5.73 g (18. 9 mmol; 94.5%) of N δ–Z–Orn–OMe isocyanate (m.p. 89°C). For 
C15H18N2O5 (306.3) calculated: 58.82% C, 5.88% H, 9.15% N; found: 58.61% C, 5.93% H, 8.98% N. This isocyanate 
(1.21 g, 3.9 mmol) was refluxed with an excess of the corresponding alcohol (20 ml) in the presence of pyridine 
(0.7 ml) for 2 h. The reaction mixture was evaporated and the resulting residue was dried in a desiccator after 
which it was triturated with anhydrous diethyl ether to obtain the product, which was used without further 
purification. 
 
The corresponding N α–R–O–CO–N δ–Z–Orn–OMe (4 mmol) in MeOH (15 ml) solution was hydrogenated on 10% 
Pd/C (100 mg) until CO2 was detected as solid BaCO3 upon reaction with Ba(OH)2. The catalyst was removed by 
filtration through charcoal and the MeOH evaporated. The residue, dissolved in acetone (10 ml), was further 
stirred with 2 M NaOH (2 ml) at room temperature for 2 h. After saponification the pH was adjusted to 3 using 
AcOH after which the acetone was evaporated. The acidic solution was applied to a Dowex column 50 × 2 
(10 ml) and washed with water (100 ml). The corresponding N α–R–O–CO–Orn–OH was released from the ion 
exchange resin by aqueous ammonia (100 ml). Evaporation of ammonia and lyophilization yielded derivatives 
2a–2e that were purified by preparative HPLC and characterized by analytical HPLC, ESI MS spectroscopy, 
elemental analysis, and electrophoresis (Table 1) and 1H NMR and 13H NMR spectroscopy (Tables 2, 3). 
 
Nα–Boc–Orn–OH, 2f (Table 1) 
The H–N δ–Z–Orn–OMe (0.29 g; 1.1 mmol) in a dioxane–water mixture (10 ml) was treated with (Boc)2O (0.24 g, 
1.1 mmol) adjusted to pH 8 by NaHCO3, for 2 h at room temperature. The dioxane was evaporated, and the 
aqueous solution was acidified using 10% citric acid. The resulting oil was taken-up in ethyl acetate (3 × 100 ml), 
dried using anhydrous Na2SO4 after which the solution was evaporated to dryness, yielding the fully protected 
ornithine derivative. Deprotection was achieved following the procedures described above to yield compound 
2f, which was purified and characterized similarly to compounds 2a–2e. 
 
NMR structure determination 
The NMR spectrum of each ornithine derivative (1a–1l and 2a–2f) was measured on a Bruker AVANCE-600 (1H at 
600.13 MHz; 13C at 150.90 MHz) spectrometer in d6-DMSO at 27°C and referenced to the solvent: 
δH(DMSO) = 2.50 and δC(DMSO) = 39.70. Chemical shifts were determined from 1D 1H and 13C NMR spectra. 
Correlated 2D-homonuclear spectra (2D-1H,1H-COSY) and 2D-heteronuclear spectra (2D-1H,13C-HSQC and 2D-
1H,13C-HMBC) were used for structural assignment of hydrogen and carbon signals. All of the NMR data are 
summarized in Tables 2 and 3. 
 
Measurement of IC50 values 
ArgE from E. coli was purified as previously described (McGregor et al. 2005). The purified enzyme exhibited a 
single band on 12% SDS-PAGE, corresponding to its calculated M r of 42,350 by comparison with molecular 
weight standards purchased from Sigma. It was subsequently concentrated to >1 mM and stored at 4°C. Protein 
concentrations were determined using the theoretical value of ε280 = 41,250 M−1 cm−1 (McGregor et al. 2007). 
 
IC50 values for each ornithine derivative were determined for ArgE (Table 1) using a spectrophotometric assay 
with NAO as the substrate, as previously described (McGregor et al. 2005). All kinetic experiments were 
performed in 50 mM Chelex-100 treated sodium phosphate buffer at pH 7.5 and 25°C. The rate of NAO 
deacetylation was monitored as a decrease in absorbance at 214 nm. Catalytic activities were determined within 
±10%. Initial rates were determined at a minimum of five inhibitor concentrations providing a dose-response 
curve indicating the concentration required for 50% inhibition (IC50) (Table 1). 
 
Antimicrobial activity determination 
A quick qualitative estimate of the antimicrobial properties of ornithine derivatives was determined utilizing the 
double-layer technique originally developed by microbial geneticists for bacteriophage titration. Briefly, petri 
dishes (90 mm in diameter) with 20 ml of LB agar were prepared. Two ml of melted “soft” agar made from LB 
broth and 0.5% agar, containing bacteria (about 107 colony forming units, CFU) were poured over the surface. 
Fresh bacterial cultures were always prepared in LB broth and added when the melted soft agar cooled to ~45°C. 
The ornithine derivatives (0.001–10 mg ml−1) in water (2 μl) were dropped onto the surface of the solidified 
upper layer, and the plates were incubated at 37°C. Clear zones of inhibition appeared within a few hours and 
remained clear for days. The potency was estimated by the diameter and clarity of the zones formed. 
 
Quantitatively, the minimal inhibitory concentration (MIC) was established by observing the growth of bacteria 
growth in multi-well plates (Mendes et al. 2004; Oren and Shai 1997; Lequin et al. 2006). Bacteria in mid-
exponential phase were added to individual wells containing test compound solutions of different 
concentrations in LB broth (0.2 ml volume and compound concentration in the range 0.5–500 μM) and 
incubated at 37°C for 20 h. The plates were shaken continuously in a Bioscreen C instrument (Helsinki, Finland), 
and absorbance measurement were recorded at 540 nm every 15 min. Routinely, 1–5 milion CFUs were used to 
determine activity (corresponding to an absorption of 0.015–0.020 units at 540 nm). Orn derivatives were tested 
in duplicate in at least three independent experiments. Tetracycline was tested as a standard in the 
concentration range 0.5–500 μM. 
 
Results and discussion 
Previously, the synthesis of some N α-acyl-derivatives of ornithine, in which the corresponding acylchlorides 
were used for acylation of H–N δ–Z–Orn–OH, was described (Hlaváček et al. 2007). However, given the large 
number of purification steps for intermediates and the limited number of compounds that could be obtained, an 
alternative route for the preparation of a larger number of ornithine derivatives (1a–1j) that eliminates 
purification steps was designed. These compounds were synthesized by acylation of N δ–Boc–l- or d–Orn bound 
to a Wang polystyrene carrier, which served as the carboxyterminal protection for this amino acid (Fig. 3). 
Coupling of the commercially available N α–Fmoc–N δ–Boc–l- or d–Orn–OH to this resin was carried out by DIC 
with HOBt as the coupling reagents in the presence of DMAP in DMF. The Fmoc protecting group was removed 
by the addition of 20% piperidine in DMF followed by the addition of a series of N α-acyl groups, using 
acetanhydride with DIEA (1a) or the corresponding carboxylic acids (1b–1j) with DIC and HOBt as the coupling 
reagents in DMF. Detachment of 1a–1j from the resin and removal of the N δ–Boc protecting groups were 
performed simultaneously in the last step of the syntheses by the addition of 95% TFA with TIS and anisole as 
scavengers. 
 
Utilization of Wang resin for carboxyterminal protection resulted in a significantly simplified method for the 
synthesis of N α-acyl-derivatives of ornithine. This method should be widely applicable for the solid phase 
synthesis of any amino acid derivative. One limitation involves the reductive alkylation of N δ–Boc–ornithine 
bound to the Wang carrier (within the preparation of derivative 1l) likely due to the close proximity of the α-
amino group to the solid support, which blocked reaction with acetaldehyde and NaBH3CN. Therefore, the 
successful synthesis of 1l was carried out in solution starting with H–N δ–Z–Orn–OMe using acetaldehyde and 
NaCNBH3 in DMF, yielding C2H5–Orn(Z)–OCH3 (Meyer et al. 1995). It should be noted that after hydrogenolytic 
side-chain deprotection, catalyzed by Pd on charcoal, the lactam 1k was found due to the intramolecular 
reaction between the methyl ester and the free δ-amino groups in the N α-ethyl-derivative (Fig. 4). While 1k was 
examined for its inhibitory potency toward ArgE, it was also used as a starting material to synthesize the linear 
ornithine derivative 1l by acidic hydrolysis in boiling 6 M HCl. 
 
Synthesis of urethane groups containing N α-alkyloxycarbonyl derivatives of ornithine was accomplished via the 
corresponding isocyanate using triphosgene in DCM (Fig. 5). Using this general synthetic method compounds 
2a–2e were prepared starting from N δ–Z–Orn–OMe, which was reacted with triphosgene under mild alkaline 
conditions to yield the corresponding isocyanate (Tsai et al. 2002). After refluxing in pyridine with a series of 
alcohols (Hlaváček et al. 1976), the corresponding Orn derivatives of general formulae N α–R–O–CO–N δ–Z–Orn–
OMe were obtained. Hydrogenation on Pd/C, followed by saponification with NaOH yielded 2a–2e, which was 
desalted using ion exchange chromatography on Dowex 50 and purified by HPLC (Table 1). Triphosgene in DCM 
was found to exhibit excellent reactivity by modifying only the α-amino group under mild alkaline conditions. 
Interestingly, no cyclization or lactam formation was observed until after N δ–Z deprotection by hydrogenolysis 
of the corresponding N α–R–O–CO–N δ–Z–Orn–OMe derivative. Finally, (CH3)3C–O–CO–Orn–OH (2f) was 
prepared by direct reaction of H–N δ–Z–Orn–OMe with (Boc)2O in a dioxane–water mixture at pH 8 adjusted 
with NaHCO3 (Moroder et al. 1976), followed by deprotection of the δ-amino and carboxyl groups, desalting and 
purification as previously described. 
 
All of the Orn derivatives synthesized were examined for their ability to inhibit the catalytic activity of ArgE. Of 
the 18 compounds synthesized, nearly all inhibited ArgE activity as evidenced by IC50 values in the μM range. 
These data indicate that all of the ornithine derivatives prepared in this study are moderately strong inhibitors of 
ArgE. The Orn derivative that provided the best inhibitory response was N α-chloroacetyl-l-ornithine (1g), which 
exhibited an IC50 value of 85 μM. Similarly, the trifluoroacetyl-(1f) and ethoxycarbonyl-(2b) ornithine derivatives 
provided IC50 values of 200 and 250 μM, respectively. It should be noted that the N α-dichloroacetyl-l-ornithine 
(1h), the N α-trichloroacetyl-d-ornithine (1j), the N α-butyryl-l-ornithine (1d), and the N α-acetyl-d-ornithine (1a) 
derivatives all exhibited moderate inhibition of ArgE providing IC50 values in the range 320–450 μM (Table 1). 
Inspection of these inhibitory data provides some clues into the active site of ArgE enzymes. The best inhibitors 
have small R groups with the relative inhibitory order CH2Cl ≫ CF3 > CHCl2 > CH3 with the d and l derivatives of 
CHCl2 inhibiting ArgE equally. This trend suggests that this R group must recognize specific binding pocket near 
to the dinuclear Zn(II) active site of ArgE. 
 
In order to determine if Orn derivatives are potential antibiotic leads their antimicrobial activity was examined 
against B. subtilis-168 and E. coli B (Table 1). A majority of these ArgE inhibitors proved to be weak or very weak 
antimicrobial agents as evidenced by the drop diffusion tests performed with B. subtilis-168. However, no 
activity was detected on E. coli, even at the highest concentration used (MIC ≫ 250 μM and no clear zone for 
10 mg/ml concentration on the agar plate). The effective derivatives (1a, 1d, 1f–1j, 2a, 2b, 2e, 2f) as determined 
from the drop diffusion test were also assayed for their MIC determination. Only five Orn derivatives (1a, 1f–1i) 
were weak inhibitors of B. subtilis-168 in the range 250–500 μM for CFUs amounting to millions of bacteria. As in 
the drop diffusion test, no MIC activity of Orn derivatives toward E. coli was found. 
 
Probably, the weak activity of Orn derivatives toward B. subtilis might correspond to a decrease or elimination of 
the hydrolytic activity of ArgE via inhibition of the amide bond cleavage in N α-acetylornithine. Above data 
correlate well with the IC50 values determined for ArgE, suggesting an indirect evidence that Orn derivatives are 
capable of getting across the cell membrane and that ArgE is the likely bacterial enzymatic target. 
 
In conclusion, the new Orn based compounds described herein represent a new class of inhibitors for ArgE 
enzymes. Interestingly, several of these compounds exhibit weak antibacterial activity toward B. subtilis. 
Therefore, ornithine provides a realistic structural platform for the design of new inhibitors for ArgE enzymes 
that may possess antimicrobial activity. In general, small molecules that are non-degradable substrate analogues 
should provide effective inhibitors of bacterial enzymes and represent a reasonable approach toward the 
development of a previously undescribed antimicrobial agent. Ultimately, refining the structural aspects of these 
substrate analog inhibitors in order to match inhibitor structural features to those of the enzyme, including 
metal binding interactions, will be crucial to the discovery of a clinically relevant antimicrobial agent. 
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